A Clustering Approach for Basket Trials Based on Treatment Response Trajectories
By: Masahiro Kojima, Keisuke Hanada, Atsuya Sato
Potential Business Impact:
Finds hidden patterns in drug test results.
Heterogeneity in efficacy is sometimes observed across baskets in basket trials. In this study, we propose a model-free clustering framework that groups baskets based on transition probabilities derived from the trajectories of treatment response, rather than relying solely on a single efficacy endpoint such as the objective response rate. The number of clusters is not predetermined but is automatically determined in a data-driven manner based on the similarity structure among baskets. After clustering, baskets within the same cluster are analyzed using a hierarchical Bayesian model. This framework aims to improve the estimation precision of efficacy endpoints and enhance statistical power while maintaining the type~I error rate at the nominal level. The performance of the proposed method was evaluated through simulation studies. The results demonstrated that the proposed method can accurately identify cluster structures in heterogeneous settings and, even under such conditions, maintain the type~I error rate at the nominal level while improving statistical power.
Similar Papers
Robust Bayesian hierarchical models for basket trials enabling joint evaluation of toxicity and efficacy
Applications
Finds cancer drugs that work and are safe.
How can methods for classifying and clustering trajectories be used for prevention trials? An example in Alzheimer's disease area
Applications
Finds hidden groups who benefit from medicine.
Calibrated Bayes analysis of cluster-randomized trials
Methodology
Makes study results more trustworthy, even with bad guesses.